Literature DB >> 381128

Idiopathic portal hypertension (perisinusoidal fibrosis) after renal transplantation.

C Nataf, G Feldmann, D Lebrec, C Degott, J M Descamps, B Rueff, J P Benhamou.   

Abstract

We report the cases of two renal transplant recipients suffering from idopathic portal hypertension, a condition characterised by increased portal venous pressure in the absence of both histological lesion of the liver and obstruction of the portal vein. In these two patients, perisnusoidal fibrosis, invisible by light microscopy, was demonstrated by electron microscopy; it is suggested that partial obstruction of hepatic sinusoids by perisinusoidal fibrosis could be the mechanism for increased portal venous pressure in all the patients with idiopathic portal hypertension. In these two patients, who received 6-mercaptopurine and azathioprine, perisinusoidal fibrosis might be the consequence of prolonged administration of these drugs.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 381128      PMCID: PMC1412455          DOI: 10.1136/gut.20.6.531

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  26 in total

1.  Portal hypertension and bleeding esophageal varices; their occurrence in the absence of both intrahepatic and extrahepatic obstruction of the portal vein.

Authors:  W A TISDALE; G KLATSKIN; W W GLENN
Journal:  N Engl J Med       Date:  1959-07-30       Impact factor: 91.245

2.  [Essential portal hypertension].

Authors:  J P BENHAMOU; R GUILLEMOT; R TRICOT; L LEGER; R FAUVERT
Journal:  Presse Med       Date:  1962-11-21       Impact factor: 1.228

3.  Portal hypertension in the absence of both liver disease and vascular obstruction.

Authors:  M C MILLER; J L BRANDT
Journal:  Am J Dig Dis       Date:  1962-05

4.  Chronic active hepatitis without hepatitis B antigenemia in renal transplant recipients. Report of three cases.

Authors:  Z Freiberger; S Anuras; R S Koff; W W Bonney
Journal:  Gastroenterology       Date:  1974-06       Impact factor: 22.682

5.  Irreversible liver damage after azathioprine.

Authors:  Z Zarday; F J Veith; M L Gliedman; R Soberman
Journal:  JAMA       Date:  1972-11-06       Impact factor: 56.272

6.  Liver injury associated with methotrexate therapy for psoriasis.

Authors:  B J Podurgiel; D B McGill; J Ludwig; W F Taylor; S A Muller
Journal:  Mayo Clin Proc       Date:  1973-11       Impact factor: 7.616

7.  Ultrastructure of the liver in non-cirrhotic portal fibrosis with portal hypertension.

Authors:  B N Tandon; R Lakshminarayanan; S Bhargava; N C Nayak; S K Sama
Journal:  Gut       Date:  1970-11       Impact factor: 23.059

8.  Chronic human schistosomiasis mansoni. Pathology of the Disse's space.

Authors:  J A Grimaud; R Borojevic
Journal:  Lab Invest       Date:  1977-03       Impact factor: 5.662

9.  Idiopathic portal hypertension.

Authors:  J P Villeneuve; P M Huet; J G Joly; D Marleau; J Côté; A Légaré; M Lafortune; P Lavoie; A Viallet
Journal:  Am J Med       Date:  1976-10       Impact factor: 4.965

10.  Portal hypertension in vinyl-chloride production workers.

Authors:  P M Smith; I R Crossley; D M Williams
Journal:  Lancet       Date:  1976-09-18       Impact factor: 79.321

View more
  17 in total

1.  A case of idiopathic portal hypertension after renal transplantation.

Authors:  N Yanagisawa; H Sugaya; K Yunomura; T Harada; T Hisauchi
Journal:  Gastroenterol Jpn       Date:  1990-10

2.  Idiopathic portal hypertension associated with cytotoxic drugs.

Authors:  P Shepherd; D J Harrison
Journal:  J Clin Pathol       Date:  1990-03       Impact factor: 3.411

3.  Long term treatment of myasthenia gravis with azathioprine.

Authors:  V Fonseca; C W Havard
Journal:  Postgrad Med J       Date:  1990-02       Impact factor: 2.401

4.  Peliosis hepatis induced by 6-thioguanine administration.

Authors:  D Larrey; E Fréneaux; A Berson; G Babany; C Degott; D Valla; D Pessayre; J P Benhamou
Journal:  Gut       Date:  1988-09       Impact factor: 23.059

5.  Idiopathic portal hypertension in renal transplant recipients: report of two cases.

Authors:  N Yoshimura; T Oka; Y Ohmori; T Yasumura; H Kohnosu; T Kobashi
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

6.  Veno-occlusive disease of the liver in patients receiving immunosuppressive therapy.

Authors:  H Weitz; J M Gokel; K Loeschke; K Possinger; M Eder
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1982

7.  Nodular regenerative hyperplasia of the liver following renal transplantation.

Authors:  J E Bredfeldt; A L Havey
Journal:  Dig Dis Sci       Date:  1981-03       Impact factor: 3.199

8.  Azathioprine induced liver disease: nodular regenerative hyperplasia of the liver and perivenous fibrosis in a patient treated for multiple sclerosis.

Authors:  F Mion; B Napoleon; F Berger; M Chevallier; S Bonvoisin; L Descos
Journal:  Gut       Date:  1991-06       Impact factor: 23.059

9.  Familial occurrence of nodular regenerative hyperplasia of the liver: a report on three families.

Authors:  J Dumortier; O Boillot; M Chevallier; F Berger; P Potier; P J Valette; P Paliard; J Y Scoazec
Journal:  Gut       Date:  1999-08       Impact factor: 23.059

10.  Ultrastructural lesions of the liver in human peliosis. A report of 12 cases.

Authors:  E S Zafrani; A Cazier; A M Baudelot; G Feldmann
Journal:  Am J Pathol       Date:  1984-03       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.